A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation

Gut and Liver

Volumn 9, Issue 2, 2015, Pages 247-250

  Gweon, Tae Geun ^a   Lee, Kyung Jin ^a   Kang, Donghoon ^a   Park, Sung Soo ^a   Kim, Kyung Hoon ^a   Seong, Hyeonjin ^a   Ban, Tae Hyun ^a   Moon, Sung Jin ^a   Kim, Jin Su ^a   Kim, Sang Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Fecal microbiota transplantation; Fulminant Clostridium difficile infection; Megacolon, toxic

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL DISTENSION; ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIARRHEA; DISEASE SEVERITY; DROWSINESS; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; FECAL MICROBIOTA TRANSPLANTATION; FECES CULTURE; FECES MICROFLORA; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PSEUDOMEMBRANOUS COLITIS; SIGMOIDOSCOPY; THORAX RADIOGRAPHY; TOXIC MEGACOLON; TRANSPLANTATION; URINE VOLUME; COMPLICATION; FECES; MEGACOLON, TOXIC; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS; MALE; MEGACOLON, TOXIC;

EID: 84923644133     PISSN: 19762283     EISSN: 20051212     Source Type: Journal    
DOI: 10.5009/gnl14152     Document Type: Article

References (12)

1. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23: 529-549.
2. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009;136:1913-1924.
3. Lamontagne F, Labbé AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245:267-272.
4. Sailhamer EA, Carson K, Chang Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009;144:433-439.
5. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-372.
6. Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant clostridium difficile infection. Am J Gastroenterol 2008;103:3195-3203.
7. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.
8. McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 2006;49:640-645.
9. Abougergi MS, Kwon JH. Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci 2011;56:19-26.
10. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012;107:761-767.
11. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012;107:1079-1087.
12. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-1084.